Drug intelligence / Profile preview

250 ppm F as MFP

Development stage
Unknown
Lead developer
Procter & Gamble
Modality
Small Molecules
Administration
Topical
01

Overview

250 ppm F as MFP is an experimental low-concentration fluoride-containing dentifrice (toothpaste) developed by The Procter & Gamble Company, in which the active ingredient is sodium monofluorophosphate (MFP) at a concentration of 250 parts per million of fluoride. It is formulated in a silica abrasive base and is used as a comparator/low-dose arm in clinical research studies evaluating the anticaries (anti-dental caries) efficacy of MFP dentifrices across a range of fluoride concentrations (e.g., 250, 1,100, and 2,800 ppm F as MFP). The drug's biological target is tooth enamel, where fluoride ions promote remineralization and inhibit demineralization, thereby protecting against dental caries. It is classified as a small molecule/topical oral care product (dentifrice), not a biologic. It does not appear to have a consumer brand name, as it is a research/experimental formulation. It has been studied in Phase 1-type randomized crossover trials evaluating salivary fluoride clearance and in situ remineralization in healthy adults, serving primarily as a dose-response reference point rather than a standalone therapeutic product.

Other names
250 ppm F MFP dentifrice250 ppm F as MFP dentifrice250 ppm F as MFP toothpastesodium monofluorophosphate 250 ppm Fsodium monofluorophosphate 250 ppm F dentifricesodium monofluorophosphate 250 ppm F toothpaste

Beyond the preview

Go deeper on 250 ppm F as MFP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 250 ppm F as MFP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call